Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Clinical Investigation of rhBMP-2 and Compression Resistant Matrix With the CD HORIZON® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease

NCT00707265 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.

NCT NCT00707265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00707265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Clinical Investigation of rhBMP-2 and Compression Resistant Matrix With the CD HORIZON® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease
Lead sponsor
Medtronic Spinal and Biologics
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2002
Completion date
February 28, 2010
Enrollment
463 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease